Rachael A. Dunlop - Concepedia

Author

Rachael A. Dunlop

Also Known As

Dunlop RA, Dunlop, R., Dunlop, Rachael Anne, R Dunlop, R. A. Dunlop, R. Dunlop, RA Dunlop, Rachael A Dunlop, Rachael A. Dunlop, Rachael Anne Dunlop

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Institute for EthnoMedicine The Heart Research Institute University of Technology Sydney The University of Sydney Centers for Disease Control and Prevention

About

Rachael A. Dunlop is an author at Institute for EthnoMedicine specializing in medicine, neuroprotection, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	615
2	Natural Sciences	3	3	115
3	Engineering	2	2	120
4	Health Sciences	1	1	10
5	Nursing	1	1	121

Rachael A. Dunlop

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of l-Serine Causing Protein Misfolding and Aggregation Rachael A. Dunlop, Paul Alan Cox, Sandra Anne Banack, PLoS ONE	2013	298
Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team Jo Hockley, Rachael A. Dunlop, R.J. Davies BMJ Palliative CareFamily MedicineNursingPrimary CareMental Health Nursing	1988	121
An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease Sandra Anne Banack, Rachael A. Dunlop, Paul Alan Cox Open Biology Mirna ComponentsEngineeringMirna SequencesNeurochemical BiomarkersNeurology	2020	92
Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols Jingmin Zeng, Rachael A. Dunlop, Kenneth J. Rodgers, Biochemical Journal	2006	77
miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis Sandra Anne Banack, Rachael A. Dunlop, Elijah W. Stommel, Journal of the Neurological Sciences Extracellular VesiclesRobust BiomarkerAmyotrophic Lateral SclerosisMedicineExtracellular Microvesicles	2022	50
l-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro Sandra W. Chan, Rachael A. Dunlop, Anthony Rowe, Experimental Neurology MedicineNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurology	2011	49
Biosynthesis and turnover of DOPA-containing proteins by human cells Kenneth J. Rodgers, Peter M. Hume, Rachael A. Dunlop, Free Radical Biology and Medicine Protein FunctionSignal TransductionProtein ExpressionBiochemistryNatural Sciences	2004	46
The impact of specific oxidized amino acids on protein turnover in J774 cells Rachael A. Dunlop, Roger T. Dean, Kenneth J. Rodgers Biochemical Journal Amino AcidsProtein AssemblyProtein TurnoverMolecular BiologyDopa Incorporation	2008	42
The use of l-serine to prevent β-methylamino-l-alanine (BMAA)-induced proteotoxic stress in vitro Brendan J. Main, Rachael A. Dunlop, Kenneth J. Rodgers Toxicon BiochemistryStressMedicineLipid PeroxidationNeuroprotection	2015	40
l-Serine-Mediated Neuroprotection Includes the Upregulation of the ER Stress Chaperone Protein Disulfide Isomerase (PDI) Rachael A. Dunlop, James T. Powell, James S. Metcalf, Neurotoxicity Research Neurodegenerative DiseasesNeuropeptidesMedicineNeuropharmacologyNeuroprotection	2017	36

Page 1